科研之友
微信
新浪微博
Facebook
分享链接
摘要
Patients with acute coronary syndrome(ACS) in the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering(MIRACL) study had diminished cardiovascular events after 16 weeks of treatment of atorvastatin 80 mg daily. We determined whether plasma lipoproteins at baseline and then at 6 weeks ...
